Go Back
SUM-44: Sensitivity to the PIK3CD inhibitor, Idelalisib
Go Back
Go Back
Go Back
Go Back
The SUM Cancer Cell Line Knowledge Base (SLKBase)
Using functional genomics to navigate critical pathways for growth and survival of breast cancer cells
Go Back
You must be logged in to post a comment.